{
    "Trade/Device Name(s)": [
        "Dimension\u00ae EXLTM with LM clinical chemistry system",
        "Dimension\u00ae FT4L Flex\u00ae reagent cartridge",
        "LOCI\u00ae Thyroid Calibrator"
    ],
    "Submitter Information": "Dade Behring Inc.",
    "510(k) Number": "K073604",
    "Predicate Device Reference 510(k) Number(s)": [
        "K944093",
        "K053531"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CEC",
        "JIT",
        "JJE"
    ],
    "Summary Letter Date": "December 20, 2007",
    "Summary Letter Received Date": "December 21, 2007",
    "Submission Date": "February 18, 2008",
    "Regulation Number(s)": [
        "21 CFR 862.1695"
    ],
    "Regulation Name(s)": [
        "Free thyroxine test system"
    ],
    "Analyte Class(es)": [
        "endocrine",
        "chemistry"
    ],
    "Analyte(s)": [
        "Free Thyroxine"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Dimension\u00ae EXLTM with LM clinical chemistry system"
    ],
    "Method(s)/Technology(ies)": [
        "Photometric",
        "Turbidimetric",
        "Chemiluminescence",
        "Integrated ion selective multisensor technology"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Analyzer",
        "Reagent",
        "Calibrator"
    ],
    "Document Summary": "FDA 510(k) summary for Dimension EXLTM with LM clinical chemistry system, FT4L Flex reagent cartridge and LOCI Thyroid Calibrator for quantitative measurement of Free Thyroxine and calibration in serum/plasma.",
    "Indications for Use Summary": "Quantitative measurement of Free Thyroxine in human serum and plasma for diagnosis and monitoring of thyroid disease; calibration of FT4L method on Dimension EXLTM with LM system.",
    "fda_folder": "Clinical Chemistry"
}